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STUDY PROTOCOL: 
ULTRASOUND DEFINITIONS AND 
FINDINGS IN GREATER 
TROCHANTERIC PAIN SYNDROME: A 
SYSTEMATIC REVIEW 
 
Version 2 – 7/10/2019 
 
Version changes 
from version 1 to version 2 are marked with yellow and includes: 
1. Introduction: Last part rephrased to clarify the gaps in current research.  
2. Objectives: Rephrased to review questions for clarity. 
3. Population and comparators: Comorbidities will be evaluated for each study individually. 
4. Exclusion criteria: Studies primarily focusing on tumors, hematomas, genetic disorders, and 
ultrasound-guided nerve block are excluded too. Injection of steroid during the last 12 
months is changed from 12 to 3 months. 
5. Inclusion criteria: Original MRI data and surgical/histopathological data are only included if 
there is original ultrasound data for comparison. 
6. Selection process: Two authors will complete the process instead of one. 
7. Data collection: One author will double-check the extracted data. Subtle changes in data 
extraction, see appendix 2. Due to limited resources, authors will not be contacted if data is 
missing. 
8. Secondary outcomes: Surgical/histopathological outcomes added. 
9. Assessment of methodical quality in individual studies: Epidemiological Appraisal 
Instrument will be used instead of Downs and Black checklist. 
10. Data synthesis: First part rephrased for clarity. 
11. Appendix 2: Subtle changes in data extraction form. Most importantly, MRI definitions will 
not be extracted and the definitions/presence of normal appearance, thickness, vascularity, 
bony abnormalities, enthesopathy and iliotibial band abnormalities will be extracted too. 
 
The rationale behind the changes is to clarify and narrow the focus of this systematic review and to 
enhance the research quality by adding another author to the selection- and data extraction process.  
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Introduction 
Rationale 
Greater trochanteric pain syndrome (GTPS) is a term given to chronic lateral hip pain and is most 
prevalent in middle-aged women (40-60 years), but is also frequently seen in runners, footballers and 
dancers. It is a common diagnosis and is estimated to affect between 10 – 25 % of the general 
population.1 
 
GTPS is characterized by tenderness on direct palpation of the lateral aspect of the hip and can be 
exacerbated by weight-bearing activities, lying on the painful site, active abduction and passive 
adduction of the hip joint.1–3 This might result in a reduction of physical activity leading to negative 
implications for general health, employment and well-being.4  
 
In 1923 “trochanteric bursitis” was described.1 However, cardinal symptoms of bursal inflammation 
like erythema, warmth and edema are usually absent and more magnetic resonance imaging (MRI), 
ultrasound and histopathological studies suggest that tendinopathy is a more evident reason than 
bursitis to GTPS.5–13 Nowadays GTPS is primarily thought to be due to tendinopathy/tearing of the 
gluteus medius tendon and/or the gluteus minimus tendon with or without coexisting bursal 
pathology.1,3 
 
In addition, chronic lateral hip pain can also be caused by iliotibial band friction disorders, 
osteoarthritis of the hip, stress fractures of the femoral neck, avascular necrosis of the femoral head, 
lumbar spine referred pain, nerve entrapment, pelvic pathology, myofascial pain among many other 
factors. These causes together with the complex etiology behind GTPS increase the risk of 
misdiagnosis.1,3,8 This emphasizes the need for good, reliable clinical tests and imaging modalities to 
increase the diagnostic accuracy in order to avoid mismanagement, which can lead to worsening of 
the prognosis and development of recalcitrant symptoms.3,14 
 
GTPS is acknowledged as a clinical diagnosis, but imaging modalities can be useful in recalcitrant 
cases or in cases with a mixed clinical picture.3  
 
Plain x-ray findings are usually normal in patients with GTPS but can be used to exclude other 
potential causes like hip osteoarthritis and stress fractures.1 
 
Ultrasound is highly effective in evaluating gluteal tendons and bursae and can further be used 
therapeutically to guide injection of steroid.1 Connell et al. describe that ultrasound can be used to 
identify gluteal tendinopathy in patients with GTPS and further that ultrasound also can be used to 
characterize the severity of disease and to discriminate tendinosis from partial- and full thickness 
tears.7 Another study found a positive predictive value of 100 % for gluteal tendons tears in 24 patients 
with GTPS and also describes the ability of ultrasound to detect bursa pathology.6 In addition, 
ultrasound is a simple, dynamic, inexpensive and radiation-free diagnostic tool and as such, it is an 
excellent imaging modality. However, ultrasound requires trained personnel, is vulnerable to 
interpersonal differences and cannot exclude intra-articular and bony causes to hip pain.1,7 
 
MRI is usually restricted to patients in whom conservative measures have failed due to its 
expensiveness and lack of availability. Though, MRI is a highly sensitive diagnostic tool regarding 
GTPS and is also sensitive to other causative pathologies of chronic lateral hip pain. In addition, no 
interpersonal differences are seen.1,7 On the other hand, MRI findings are also seen in asymptomatic 
people and may therefore not be entirely specific.11,15,16 For that reason Grimaldi et al. recommends 
that positive MRI findings always should be backed up by positive palpation of the hip and at least 
one active clinical test in order to diagnose GTPS as the cause to chronic lateral hip pain.17 
 
A limitation in identifying specific structural diagnoses is that both ultrasound and MRI rely on 
radiological interpretation. Docking et al. states that there is no consensus around the features that 
differentiate between the most common finding in GTPS: Tendinosis, partial- and full-thickness tears 
and bursitis. This lack of consensus leads to inability to reliably distinguish between the various 
categories and contributes to poor accuracy.13 
 
To our knowledge, no golden standard is recognized in the diagnostic approach of GTPS. MRI is 
highly sensitive and often used as golden standard, but detection of abnormalities on MRI is a poor 
predictor of pain because pathological MRI findings are seen in both symptomatic and asymptomatic 
patients. For that reason, a study by Ganderton et al. states that MRI does not provide an accurate 
evaluation of GTPS and that a diagnostic golden standard of GTPS yet has to be identified.15,16 Some 
studies have used surgical and histopathological findings as golden standard, but these studies are 
demanding and have a low sample size ranging from 5-24 patients, lowering their power.6,7,12,13 
 
All together ultrasound seems to be an excellent first choice of imaging modality to diagnose the 
etiology behind GTPS due to its high sensitivity, ease of access and low cost. However, there are no 
clear ultrasound definitions on the most common findings in GTPS and the prevalence of these 
findings is not systematically described. Additionally, the diagnostic accuracy of ultrasound plus the 
association between ultrasound- and MRI findings in patients suffering from GTPS are last 
systematically described in 2012 by McMahon et al.14 More studies have been published since,13,18,19 
justifying an updated systematic review of the literature. 
 
Review questions 
Primary objectives 
1. How are the classical ultrasound findings in GTPS methodical defined across different 
studies? (e.g. tendinitis, tendinosis, partial and full-thickness tears, bursitis and 
calcifications?) 
2. What is the prevalence of ultrasound findings in patients with clinical GTPS? 
 
Secondary objectives 
3. How accurate is ultrasound in the diagnosis of patients with GTPS compared to 
surgical/histopathological findings? 
4. What is the association between ultrasound- and MRI findings in patients diagnosed with 
GTPS? 
  
Methods 
We will conduct a systematic review following the PRISMA statement and prospectively register the 
review in PROSPERO.20 
 
Search strategy and information sources 
We will carry out a systematic search in the following bibliographic databases: PubMed, Embase and 
Cochrane Central Register of Controlled Trials. A hand search of the reference lists of relevant 
articles will also be conducted for other relevant references. There will be no restrictions in year of 
publication, but only articles reported in English or Danish will be included. Unpublished studies and 
abstracts will not be included.  
 
The following search strategy was tested to be the most efficient across databases and will be applied 
in all databases mentioned above, see appendix 1: 
 
Target condition 
(("lateral") AND "hip") AND "pain" OR 
"trochanter" OR "trochanteric" OR 
"gluteal" OR "gluteus"  OR 
"gtps"   OR 
"iliotibial"   OR 
"peritrochanteric" 
 
AND 
 
Imaging modalities 
"ultrasound"   OR 
"ultrasonography"  OR 
"mri"   OR 
"magnetic resonance" 
 
There will be performed a re-run of the search just prior to the final analyses. 
 
Eligibility criteria 
Study design and setting 
To increase the number of eligible studies we will include any type of study design and setting, except 
case reports, case series and evidence synthesis such as systematic reviews.  
 
Population and comparators 
The study populations must include patients suffering from GTPS. Subjective symptoms, as well as 
patients diagnosed with GTPS in a clinical setting, will be accepted. However, possible causes to 
GTPS anticipated to be included are gluteus medius or minimus tendinopathies or tears and 
trochanteric bursitis. An asymptomatic control group for comparison is desirable but is not a 
requirement.  
 
Only studies examining adults (18 years or older) will be included. Though, studies addressing both 
adults and children with separate data will be included too. The influence of potential comorbidities 
will be evaluated for each study individually. Otherwise, there will be no restrictions regarding 
gender, disease status and level of physical activity. 
 
Exclusion criteria 
Studies including patients with injections of steroid during the last 3 months, patients who had 
undergone hip arthroplasty, and studies primarily focusing on hip fractures, intraarticular pathology, 
tumors, hematomas, genetic disorders, infections and ultrasound-guided nerve blocks will be 
excluded. Finally, studies on animals and cadavers will be excluded too.  
 
Imaging modalities and outcomes 
This systematic review will investigate the properties of ultrasound in the diagnostic process of GTPS 
and secondly evaluate the association between ultrasound-, MRI- and surgical/histopathological 
findings. Therefore, studies must include original ultrasound data in order to be included. Details 
about gluteus medius, gluteus minimus or bursae of the lateral hip region must be obtainable. Original 
MRI data and surgical/histopathological data will only be included if there is original ultrasound data 
on the same group of patients for comparison.   
 
Selection process 
Studies identified through the search process will be downloaded to “Covidence”, whereupon 
duplicates are removed. Then, two authors (MH and MSR) will screen for potential studies based on 
titles and abstracts and subsequently perform a full-text evaluation of the selected studies. Studies 
which fulfil the eligibility criteria will be included in the review. Disagreement between the two 
authors will be solved by discussion. If consensus is not achieved, a third author will be involved 
(JLO). 
 
Data collection 
One author will collect data from the included studies using a specifically designed standardized 
data extraction form (Appendix 2), while another author (MSR) will double-check the extracted 
data. The following data will be extracted: 
- General study information 
- Study design and setting 
- Characteristics of study population and participants 
- Ultrasound definitions of GTPS pathology (normal appearance, thickness, vascularity, 
bursitis, tendinosis, tendinitis, partial- and full-thickness tears, calcifications, bony 
abnormalities, enthesopathy and iliotibial band abnormalities) 
- Outcome measures 
o The presence of pathological changes verified by ultrasound 
o The presence of pathological changes verified by surgery/histopathology in order to 
calculate diagnostic accuracy of ultrasound 
§ Whenever possible, data will be extracted or analyzed to provide sensitivity, 
specificity, positive predictive value and negative predictive value. 
o Original MRI data compared to original ultrasound data 
 
Primary outcomes 
The primary outcomes are how the included studies define the typical ultrasound findings in GTPS 
(normal appearance, thickness, vascularity, bursitis, tendinosis, tendinitis, partial- and full-thickness 
tears, calcifications, bony abnormalities, enthesopathy and iliotibial band abnormalities) and the 
presence of these ultrasound findings in patients with GTPS. 
 
Secondary outcomes 
Secondary outcomes are the presence of MRI findings and surgery/histopathological findings in 
patients with GTPS. 
 
Assessment of methodical quality in individual studies 
This systematic review potentially includes both randomized controlled trials and non-randomized 
studies why the Epidemiological Appraisal Instrument (EAI) will be used to assess the methodical 
quality in the included studies. Only circumstances concerning ultrasound definitions and -findings 
will be evaluated. EAI is a 43 items tool, which is a valid and reliable appraisal instrument for 
systematic reviews. Its applicable for multiple types of study designs and assesses various 
components like study description, subject selection, measurement quality, data analysis and 
generalization of results.21 Items will be scored yes (score = 2), partial (score = 1), no (score = 0), 
unable to determine (score = UTD) or not applicable (NA). The items concerning exposure (item 2, 
25-27) will be interpreted as the characterization of GTPS. Characteristics of study participants (item 
8) must include age, gender, disease duration and BMI to score “yes”. Observers need to be blinded 
for symptoms, clinical test results and possible reference standards to score “yes” (item 29).  
 
To further assess the methodical quality in primary diagnostic accuracy studies included in this 
review, QUADAS-2 will be applied. This checklist assesses the risk of bias across 4 different 
categories: Patient selection (bias in the selection of patients?); index test (bias in the interpretation 
of the index test?); reference standard (bias when comparing to the reference standard?) and flow and 
timing (bias in the flow of patient? e.g. was there an appropriate interval between index and reference 
test?). Each category will be judged as high- or low risk of methodological quality issues. If 
insufficient information is provided the term “unclear” will be given.22 
 
The assessments will be completed by one author (MH) and supervisors (MSR and JLO) will be 
involved in ambiguous cases. 
 
Data synthesis 
The primary focus for this systematic review is a narrative synthesis. At first, the characteristics of 
the included studies will be presented followed by an evaluation of methodical quality. After this, the 
primary outcomes will be discussed. Here the various definitions of ultrasound findings in GTPS will 
be presented and the presence of these findings in patients with GTPS will be explored. Subsequently, 
the diagnostic accuracy of ultrasound in patients suffering from GTPS with surgery/histopathology 
as reference standard will be discussed. At last, MRI findings and ultrasound findings will be 
compared in patients with GTPS.  
 
The focus for the data synthesis will be on studies reporting detailed definitions of ultrasound 
findings, on studies presenting ultrasound findings in both symptomatic and asymptomatic patients 
and on studies comparing ultrasound findings to either MRI or surgery/histopathological findings.  
 
Studies of any level of methodical quality will be retained in the analysis.  
 
If sufficient data is available in the included studies a meta-analysis will be performed. In this the aim 
will be to investigate the likelihood of ultrasound findings in patients with and without GTPS. 
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Appendix 1 – Preliminary search results 5/8/2019 
PubMed Database search results 
Line Search Term Results 
1 (("lateral") AND "hip") AND "pain" 1442 
2 ("trochanter") OR "trochanteric" 7987 
3 ("gluteal") OR "gluteus" 8433 
4 "gtps" 249 
5 "iliotibial" 1007 
6 "peritrochanteric" 188 
7 1 or 2 or 3 or 4 or 5 or 6 18155 
8 "ultrasound" 256894 
9 "ultrasonography" 310325 
10 "mri" 232298 
11 "magnetic resonance" 702150 
12 8 or 9 or 10 or 11 1141696 
13 7 and 12 2012 
 
Embase Database search results 
Line Search Term Results 
1 (("lateral") AND "hip") AND "pain" 3253 
2 ("trochanter") OR "trochanteric" 11311 
3 ("gluteal") OR "gluteus" 12643 
4 "gtps" 327 
5 "iliotibial" 1309 
6 "peritrochanteric" 252 
7 1 or 2 or 3 or 4 or 5 or 6 27284 
8 "ultrasound" 459458 
9 "ultrasonography" 202324 
10 "mri" 408668 
11 "magnetic resonance" 1263525 
12 8 or 9 or 10 or 11 1797613 
13 7 and 12 4306 
 
Cochrane Database search results 
Line Search Term Results 
1 (("lateral") AND "hip") AND "pain"   
2 ("trochanter") OR "trochanteric"   
3 ("gluteal") OR "gluteus"   
4 "gtps"   
5 "iliotibial"   
6 "peritrochanteric"   
7 1 or 2 or 3 or 4 or 5 or 6 18 
8 "ultrasound"   
9 "ultrasonography"   
10 "mri"   
11 "magnetic resonance"   
12 8 or 9 or 10 or 11 292 
13 7 and 12 4 
 
  
Appendix 2 – Data extraction form 
General study information 
Title  
Study ID (surname of first author and year first 
full report of study was published e.g. Smith 
2001) 
 
Journal  
Country  
Notes: 
 
Study design and setting 
Aim of study  
Design  
Setting  
Recruitment period  
Notes: 
 
Study population and participants 
Study population description  
Inclusion criteria  
Exclusion criteria  
Notes 
 
Baseline characteristics 
Variables Total 
n =   
With GTPS 
n =  
Without GTPS 
n =  
Subgroup X 
n = 
Age     
Gender (W/M)     
Height     
Weight     
BMI     
Duration of 
symptoms until 
imaging 
    
Other     
Notes     
 
Data collection 
Ultrasound – Definitions 
Equipment  
Investigator  
Procedure  
Normal  
Thickness  
Vascularity  
Bursitis  
Tendinosis  
Tendinitis  
Partial tear  
Full thickness tear  
Calcifications  
Bony abnormalities  
Enthesopathy  
Iliotibial band abnormalities  
Notes: 
 
Outcomes 
Ultrasound – Findings 
Normal  
Thickness  
Vascularity  
Bursitis  
Tendinosis  
Tendinitis  
Partial tear  
Full thickness tear  
Calcifications  
Bony abnormalities  
Enthesopathy  
Iliotibial band abnormalities  
Notes: 
 
Ultrasound – Diagnostic accuracy 
Condition: e.g. tendinosis, 
full-thickness tear, bursitis 
Surgery/Histopathology  
Condition 
positive 
Condition 
negative 
Total 
Ultrasound Test outcome 
positive 
   
Test outcome 
negative 
   
 Total    
 
Sensitivity  
Specificity  
Positive predictive value  
Negative predictive value  
+ Likelihood ratio  
- Likelihood ratio  
Accuracy  
 
 
Original MRI data for comparison 
 
 
Conclusion 
Primary outcome:  
 
 
 
